Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation
X Yao, NS Abraham, LR Sangaralingham… - Journal of the …, 2016 - Am Heart Assoc
Background The introduction of non–vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
X Yao, NS Abraham, LR Sangaralingham… - Journal of the …, 2016 - europepmc.org
Background The introduction of non–vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
X Yao, NS Abraham, LR Sangaralingham… - Journal of the American …, 2016 - cir.nii.ac.jp
抄録< jats: sec xml: lang=" en">< jats: title> Background</jats: title>< jats: p xml: lang=" en">
The introduction of non–vitamin K antagonist oral anticoagulants has been a major advance …
The introduction of non–vitamin K antagonist oral anticoagulants has been a major advance …
Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation
X Yao, NS Abraham… - Journal of the …, 2016 - mayoclinic.pure.elsevier.com
Background-The introduction of non-vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
[HTML][HTML] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
X Yao, NS Abraham, LR Sangaralingham… - Journal of the …, 2016 - ncbi.nlm.nih.gov
Background The introduction of non–vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
X Yao, NS Abraham… - Journal of the …, 2016 - pubmed.ncbi.nlm.nih.gov
Background The introduction of non-vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
[PDF][PDF] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
X Yao, NS Abraham, LR Sangaralingham, MF Bellolio… - 2016 - academia.edu
Background-—The introduction of non–vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation
X Yao, NS Abraham… - Journal of the …, 2016 - mayoclinic.elsevierpure.com
Background-The introduction of non-vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
[PDF][PDF] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
X Yao, NS Abraham, LR Sangaralingham, MF Bellolio… - 2016 - researchgate.net
Background-—The introduction of non–vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
[PDF][PDF] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
X Yao, NS Abraham, LR Sangaralingham, MF Bellolio… - 2016 - pdfs.semanticscholar.org
Background-—The introduction of non–vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …